Frederik E. Stuurman

Author

Also Known As

F E Stuurman, F. E. Stuurman, F.E. Stuurman, Frederik E Stuurman, Frederik E. Stuurman, Frederik Stuurman, Stuurman, F.E.

Publications

893

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Centre for Human Drug Research The Netherlands Cancer Institute Utrecht University Oncode Institute

About

Frederik E. Stuurman is an author at Leiden University Medical Center specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	259
2	Health Sciences	3	3	84
3	Engineering	1	1	84
4	Applied Physiology	1	1	54
5	Biomedical Engineering	1	1	84

Frederik E. Stuurman

Publications

558

Citations

H-Index

Page 1

	Year	Citations
Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings R.C.A. Schellekens, Frans Stellaard, Dragana Mitrović, Journal of Controlled Release EngineeringPolymer-drug ConjugateMedicineResponsive PolymersPulsatile Drug Delivery	2008	84
A novel dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products R.C.A. Schellekens, Frederik E. Stuurman, F.H.J. van der Weert, European Journal of Pharmaceutical Sciences Pharmaceutical ScienceMedicineIntestinal Release BehaviourPharmaceutical TechnologyAnalytical Chemistry	2006	60
Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial Jules A. A. C. Heuberger, Joris I. Rotmans, Pim Gal, The Lancet Haematology Physical ActivityKinesiologyExerciseExercise PhysiologyPhysical Exercise	2017	54
Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis Amee Sonigra, Hendrik J. Nel, Pascale Wehr, JCI Insight	2022	44
Repeatability and predictive value of lactate threshold concepts in endurance sports Jules A. A. C. Heuberger, Pim Gal, Frederik E. Stuurman, PLoS ONE	2018	43
Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors Frederik E. Stuurman, Emile E. Voest, Ahmad Awada, Investigational New Drugs Gemcitabine DerivativeOncologyMedicineAdvanced Solid TumorsOral Cp-4126	2013	33
Technical validity and usability of a novel smartphone‐connected spirometry device for pediatric patients with asthma and cystic fibrosis Matthijs D. Kruizinga, Esmée Essers, Frederik E. Stuurman, Pediatric Pulmonology	2020	33
A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir Vincent A. de Weger, Frederik E. Stuurman, Jeroen J. M. A. Hendrikx, European Journal of Cancer Dose-escalation StudyMedicineClinical TrialsWeekly Oral DocetaxelClinical Pharmacology	2017	25
A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir Vincent A. de Weger, Frederik E. Stuurman, Stijn L.W. Koolen, Clinical Cancer Research	2019	22
Towards remote monitoring in pediatric care and clinical trials—Tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity, heart rate and sleep in healthy children Matthijs D. Kruizinga, N. van der Heide, Allison C. Moll, PLoS ONE	2021	22

Page 1